Eksemestan (Norwegian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Eksemestan" in Norwegian language version.

refsWebsite

Global rank Norwegian rank

5^th place

13^th place

4^th place

23^rd place

2^nd place

9^th place

low place

318^th place

1,581^st place

5,149^th place

2,374^th place

3,358^th place

doi.org

Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Láng, István; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J. (10. juli 2014). «Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer». New England Journal of Medicine. 2 (på engelsk). 371: 107–118. ISSN 0028-4793. PMC 4175521 . PMID 24881463. doi:10.1056/NEJMoa1404037. Besøkt 29. mars 2023. CS1-vedlikehold: PMC-format (link)
Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Colleoni, Marco; Burstein, Harold J.; Tondini, Carlo; Pinotti, Graziella; Spazzapan, Simon; Ruhstaller, Thomas (juli 2015). «Adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression: patient-reported outcomes in the TEXT and SOFT randomised trials». The Lancet. Oncology. 7. 16: 848–858. ISSN 1470-2045. PMC 4562429 . PMID 26092816. doi:10.1016/S1470-2045(15)00049-2. Besøkt 29. mars 2023.

«Exemestan Sandoz «Sandoz» - Felleskatalogen». www.felleskatalogen.no. Besøkt 29. mars 2023.

«Exemestane: MedlinePlus Drug Information». medlineplus.gov (på engelsk). Besøkt 29. mars 2023.

Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Láng, István; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J. (10. juli 2014). «Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer». New England Journal of Medicine. 2 (på engelsk). 371: 107–118. ISSN 0028-4793. PMC 4175521 . PMID 24881463. doi:10.1056/NEJMoa1404037. Besøkt 29. mars 2023. CS1-vedlikehold: PMC-format (link)

Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Láng, István; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J. (10. juli 2014). «Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer». New England Journal of Medicine. 2 (på engelsk). 371: 107–118. ISSN 0028-4793. PMC 4175521 . PMID 24881463. doi:10.1056/NEJMoa1404037. Besøkt 29. mars 2023. CS1-vedlikehold: PMC-format (link)
Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Colleoni, Marco; Burstein, Harold J.; Tondini, Carlo; Pinotti, Graziella; Spazzapan, Simon; Ruhstaller, Thomas (juli 2015). «Adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression: patient-reported outcomes in the TEXT and SOFT randomised trials». The Lancet. Oncology. 7. 16: 848–858. ISSN 1470-2045. PMC 4562429 . PMID 26092816. doi:10.1016/S1470-2045(15)00049-2. Besøkt 29. mars 2023.

Pagani, Olivia; Regan, Meredith M.; Walley, Barbara A.; Fleming, Gini F.; Colleoni, Marco; Láng, István; Gomez, Henry L.; Tondini, Carlo; Burstein, Harold J. (10. juli 2014). «Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer». New England Journal of Medicine. 2 (på engelsk). 371: 107–118. ISSN 0028-4793. PMC 4175521 . PMID 24881463. doi:10.1056/NEJMoa1404037. Besøkt 29. mars 2023. CS1-vedlikehold: PMC-format (link)
Bernhard, Jürg; Luo, Weixiu; Ribi, Karin; Colleoni, Marco; Burstein, Harold J.; Tondini, Carlo; Pinotti, Graziella; Spazzapan, Simon; Ruhstaller, Thomas (juli 2015). «Adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression: patient-reported outcomes in the TEXT and SOFT randomised trials». The Lancet. Oncology. 7. 16: 848–858. ISSN 1470-2045. PMC 4562429 . PMID 26092816. doi:10.1016/S1470-2045(15)00049-2. Besøkt 29. mars 2023.